Patents by Inventor Pavel I. Reyes

Pavel I. Reyes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210190717
    Abstract: This document discloses a hybrid and multifunctional biosensing technology consisting of a dual gate thin-film transistor (DGTFT) biosensor with an extended gate covered with magnesium zinc oxide nanostructures (MZOnano) and an MZOnano modified bulk acoustic wave resonator (MZOnano BAW). The technology is used for the full-scale dynamic monitoring of bacterial biofilm formation from its early stage to the maturation stage.
    Type: Application
    Filed: December 24, 2020
    Publication date: June 24, 2021
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Yicheng Lu, Pavel I. Reyes, Guangyuan Li, Yifan Wu, Xilin Zhao
  • Patent number: 10801879
    Abstract: A magnesium zinc oxide (MZO) nanostructure modified quartz crystal microbalance (MZOnano-QCM) takes advantage of the unique sensing ability and biocompatibility of MZO-based nanostructures, and combines them with the dynamic impedance spectrum capability of the bulk acoustic wave (BAW) devices including QCM, to form a real-time, noninvasive and label-free cell monitoring biosensor, specifically detecting the susceptibility and resistance of bacterial and fungal strains and cancer cells to various antibiotic and antifungal drugs and anticancer drugs, respectively.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: October 13, 2020
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Yicheng Lu, Pavel I. Reyes, Steven Zheng, Andrew Zheng, Keyang Yang
  • Publication number: 20180209836
    Abstract: A magnesium zinc oxide (MZO) nanostructure modified quartz crystal microbalance (MZOnano-QCM) takes advantage of the unique sensing ability and biocompatibility of MZO-based nanostructures, and combines them with the dynamic impedance spectrum capability of the bulk acoustic wave (BAW) devices including QCM, to form a real-time, noninvasive and label-free cell monitoring biosensor, specifically detecting the susceptibility and resistance of bacterial and fungal strains and cancer cells to various antibiotic and antifungal drugs and anticancer drugs, respectively.
    Type: Application
    Filed: March 21, 2018
    Publication date: July 26, 2018
    Inventors: Yicheng Lu, Pavel I. Reyes, Steven Zheng, Andrew Zheng, Keyang Yang